EXEGET

Exemestane is the latest in the family of aromatase inhibitors which provide the convenience of long-term oral therapy in a large sub-group of breast cancer patients.

Exemestane is the latest in the family of aromatase inhibitors which provide the convenience of long-term oral therapy in a large sub-group of breast cancer patients.

 

Indications:

  • For adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to exemestane for completion of a total of five consecutive years of adjuvant hormonal therapy
  • For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy
Generic Name Strength Standard Type Packing Pack Size
Exemestane 25 mg IP Tab. Strip  1x10s